Quidel Stock Price

-2.26 (-1.99%)


52 Week Range


Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Quidel Corp QDEL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.26 -1.99% 111.54 17:56:20
Open Price Low Price High Price Close Price Prev Close
113.00 110.05 113.13 111.82 113.80
Bid Price Ask Price Spread News
111.54 112.96 1.42 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,415 455,654 $ 111.07 $ 50,610,688 805,004 103.3113 - 324.25
Last Trade Time Type Quantity Stock Price Currency
17:56:20 formt 300 $ 111.54 USD

Quidel Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 4.75B 42.55M 33.22M $ 1.66B $ 845.96M 18.59 5.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 16.17k 10.70%

more financials information »

Quidel News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical QDEL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week115.03118.24109.89113.20401,928-3.49-3.03%
1 Month116.67125.87103.3113110.77804,470-5.13-4.4%
3 Months125.31139.418103.3113116.60843,720-13.77-10.99%
6 Months195.50265.00103.3113154.16907,177-83.96-42.95%
1 Year211.52324.25103.3113186.341,005,487-99.98-47.27%
3 Years69.55324.2544.27152.03568,55641.9960.37%
5 Years17.64324.2516.63126.11443,81293.90532.31%

Quidel Description

Quidel Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. It is separated into four product categories: Rapid immunoassays, Cardiac immunoassays, Specialized diagnostic solutions and Molecular diagnostic solutions. Rapid immunoassay and Cardiac immunoassay tests for use in physician offices, hospital laboratories and emergency departments, retail clinics, eye health settings, pharmacies and other urgent care sites, Specialized diagnostic solutions, including direct fluorescent assays and culture-based tests, and Molecular diagnostic tests across a number of hospitals, moderately complex physician offices, laboratories and other segments. The company generates a majority of its revenue from the rapid immunoassays.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.